281
Views
5
CrossRef citations to date
0
Altmetric
Haematology: Original Article

Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

, , , , , , , , , & show all
Pages 57-67 | Accepted 07 Nov 2011, Published online: 23 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Johan Vansteenkiste, Isabelle Wauters, Steven Elliott, John Glaspy & Michael Hedenus. (2013) Chemotherapy-induced anemia: the story of darbepoetin alfa. Current Medical Research and Opinion 29:4, pages 325-337.
Read now

Articles from other publishers (3)

Ylenia Ingrasciotta, Francesco Giorgianni, Ilaria Marcianò, Jenny Bolcato, Roberta Pirolo, Alessandro Chinellato, Valentina Ientile, Domenico Santoro, Armando A. Genazzani, Angela Alibrandi, Andrea Fontana, Achille P. Caputi & Gianluca Trifirò. (2016) Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study. PLOS ONE 11:5, pages e0155805.
Crossref
César A. Rodríguez Sánchez, Adrián Alegre, Javier Cassinello, Laura Gutiérrez, Carlos Crespo, Alba Villacampa & Evelyn Walter. (2013) Coste-efectividad del tratamiento de la anemia inducida por quimioterapia con agentes estimuladores de la eritropoyesis. PharmacoEconomics Spanish Research Articles 11:4, pages 109-121.
Crossref
Nataša Debeljak, Peter Solár & Arthur J. Sytkowski. (2014) Erythropoietin and Cancer: The Unintended Consequences of Anemia Correction. Frontiers in Immunology 5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.